Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Aravindhan Veerapandiyan to Muscular Dystrophy, Duchenne

This is a "connection" page, showing publications Aravindhan Veerapandiyan has written about Muscular Dystrophy, Duchenne.

 
Connection Strength
  
 
 
3.287
  
  1. Hamid OA, Hester DM, Matesanz SE, Wright S, Batley KY, Proud CM, Veerapandiyan A. Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy: A Call for Discussion. Pediatr Neurol. 2024 Oct; 159:33-34.
    View in: PubMed
    Score: 0.912
  2. Veerapandiyan A, Rao VK. Palliative care in Duchenne muscular dystrophy: Goals of care discussions and beyond. Muscle Nerve. 2022 06; 65(6):627-629.
    View in: PubMed
    Score: 0.778
  3. Veerapandiyan A, Wagner KR, Apkon S, McDonald CM, Mathews KD, Parsons JA, Wong BL, Eichinger K, Shieh PB, Butterfield RJ, Rao VK, Smith EC, Proud CM, Connolly AM, Ciafaloni E. The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic. Muscle Nerve. 2020 07; 62(1):41-45.
    View in: PubMed
    Score: 0.680
  4. Baldi O, Kinnett K, Schrader R, Denger B, Truba N, Sorensen S, Veerapandiyan A, Colvin MK. Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy. Muscle Nerve. 2025 Mar; 71(3):377-383.
    View in: PubMed
    Score: 0.234
  5. Truba N, Sorensen S, Bearden R, Haley B, Spray B, Kinnett K, Schrader R, Veerapandiyan A, Colvin MK. The BELS questionnaire: A novel screening tool for neurodevelopmental and psychiatric symptoms in pediatric dystrophinopathy. Muscle Nerve. 2025 Feb; 71(2):153-158.
    View in: PubMed
    Score: 0.233
  6. Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med. 2025 Jan; 31(1):332-341.
    View in: PubMed
    Score: 0.231
  7. Zaidman CM, Goedeker NL, Aqul AA, Butterfield RJ, Connolly AM, Crystal RG, Godwin KE, Hor KN, Mathews KD, Proud CM, Kula Smyth E, Veerapandiyan A, Watkins PB, Mendell JR. Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy. J Neuromuscul Dis. 2024; 11(3):687-699.
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.